Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CT 2584

Known as: CT-2584, CT2584, CT2584 HMS 
A substance that is being studied in the treatment of cancer. It may prevent the growth of blood vessels from surrounding tissue into a solid tumor.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
  • R. Bonfil
  • Current opinion in investigational drugs
  • 2001
  • Corpus ID: 22139733
CT-2584, an anticancer agent that inhibits phospholipid signaling, is under development by Cell Therapeutics Inc (CTI) as a… Expand
2001
2001
 
2000
2000
De novo production of phosphatidic acid (PA) in tumor cells is required for phospholipid biosynthesis and growth of tumor cells… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
2000
2000
CT-2584 HMS, 1-(11-dodecylamino-10-hydroxyundecyl)-3,7-dimethylxanthine-hydrogen methanesulphonate, is a modulator of… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
1999
1999
A HPLC assay and solid-phase extraction technique from human plasma has been developed and validated for the novel anticancer… Expand
Highly Cited
1997
Highly Cited
1997
Natural killer-enhancing factor (NKEF) was identified and cloned on the basis of its ability to increase NK cytotoxicity. Two… Expand
1997
1997
Hepatocellular carcinoma (HCC) frequently overexpresses the MDR1 gene and is resistant to drugs transported by the multidrug… Expand